TriLink Dye-labeled mRNA现货供应

上海金畔生物科技正规代理Trilink产品,zui近市场出现Trilink的假货,为了您的实验安全请选择正牌代理。 :

 

 

TriLink BioTechnologies——高品质常规/特殊核苷酸产品
TriLink BioTechnologies公司是世界的核酸修饰技术领域的,成立于1996年,总部设在San Diego,California。TriLink公司致力于高品质核酸修饰产品的研发和生产,提供包括核苷酸、常规及核苷三磷酸特殊修饰的寡核苷酸定制(oligonucleotides),m RNA合成,CleanAmp?PCR产品,phosphoramidites和其他小分子在内的众多产品。近二十年来,TriLink一直是诊断和OEM市场核酸产品供应的行业,产品应用于基因治疗,核苷类化疗,寡核苷酸治疗和诊断领域。此外,TriLink还可提供特殊核苷酸、m RNA定制,合同研究服务和ISO/ QSR标准的cGMP生产设施。TriLink完善的产品及研发服务解决方案有助于推动药物发现和生物医学研究。

经过18年的发展, TriLink已经成为高品质RNA合成领域的,为广大科研工作者提供的mRNA及长链RNA(长可达几个Kb),并且定制修饰。同时我们也提供成品mRNA产品,包括报告基因及 mRNA表达因子。

Dye-labeled mRNA

Synthetic mRNA is at the cutting-edge of nucleic acid-based therapeutics. Unlike DNA plasmids and viral vectors, mRNA does not require a nuclear localization signal and it carries negligible risk for genomic integration. However, delivery methods are still evolving and little is known about how they affect mRNA localization and trafficking, which ultimay influence translation and function. To aid in this discovery, TriLink has expanded its offerings to include fluorescent dye-labeled mRNA. This allows for the direct visualization of the mRNA through the incorporation of labeled NTPs. 

Cyanines are fluorescent dyes that are commonly used for life science applications. Cyanine-labeled NTPs incorporate efficiently into RNA transcripts via T7 polymerase. Importantly, cyanine5-labeled mRNA has also been shown to translate.

产品如下:

货号 品名 规格 价格 品牌
Dye-labeled mRNA
L-7702 CleanCap™ Cyanine 5 FLuc mRNA (5moU)  100 μg 8925  TriLink BioTechnologies
L-7702 CleanCap™ Cyanine 5 FLuc mRNA (5moU) 1 mg  47175  TriLink BioTechnologies
L-7702 CleanCap™ Cyanine 5 FLuc mRNA (5moU) 5 mg (5 x 1 mg)  167025  TriLink BioTechnologies
L-7701 CleanCap™ Cyanine 5 EGFP mRNA (5moU) 100 μg  10115  TriLink BioTechnologies
L-7701 CleanCap™ Cyanine 5 EGFP mRNA (5moU) 1 mg  53125  TriLink BioTechnologies
L-7701 CleanCap™ Cyanine 5 EGFP mRNA (5moU) 5 mg (5 x 1 mg)  191250  TriLink BioTechnologies

L-7702
CleanCap™ Cyanine 5 FLuc mRNA (5moU)
CleanCap™ Cyanine 5 Firefly Luciferase mRNA (5-methoxyuridine) 

mRNA Length: 1,921 nucleotides

Concentration: 1.0 mg/mL

Buffer: 1 mM Sodium Citrate, pH 6.4

Identity & Purity:

Agarose Gel Mobility; Pass

Concentration ± 5%; Pass

Product Insert
SDS

CleanCap™ Cyanine 5 FLuc mRNA is designed for the analysis of mRNA delivery and translation efficiency. The FLuc mRNA will express a luciferase protein, originally isolated from the firefly, Photinus pyralis. FLuc is commonly used in mammalian cell culture to measure both gene expression and cell viability. It emits bioluminescence in the presence of the substrate, luciferin. When labeled with cyanine 5, FLuc mRNA can be directly visualized. CleanCap™ Cyanine 5 FLuc mRNA is an ideal molecule to determine mRNA delivery and localization independent of translation.

Cyanine 5 is a synthetic fluorescent dye with maximum excitation and emission wavelengths of 650 nm and 670 nm respectively. TriLink’s CleanCap™ Cyanine 5 FLuc mRNA is transcribed with Cyanine 5-UTP:5-Methoxy-UTP at a ratio of 1:3. Substitution in this ratio results in mRNA that is easily visualized and can still be translated in cell culture. Translation efficiency correlates inversely with Cyanine 5-UTP substitution. 

This mRNA is capped using CleanCap™, TriLink's proprietary co-transciptional capping method, which results in the naturally occuring Cap 1 structure with high capping efficiency. It is polyadenylated, modified with 5-methoxyuridine and optimized for mammalian systems. It mimics a fully processed mature mRNA.

Certificate(s) of Analysis

TD-OF04A

L-7702 is a replacement for L-6401.

Not for resale without express written permission. Not for use in humans. No license under any patent or patent pending is granted or implied by the purchase of any TriLink product. TriLink does not warrant that the use or sale of the products delivered hereunder will not infringe the claims of any United States or other patents or patents pending covering the use of the product alone or in combination with other products or in the operation of any process. All and any use of TriLink product is the purchaser’s sole responsibility.

L-7701
CleanCap™ Cyanine 5 EGFP mRNA (5moU)
CleanCap™ Cyanine 5 Enhanced Green Fluorescent Protein mRNA (5-methoxyuridine) 

mRNA Length: 996 nucleotides

Concentration: 1.0 mg/mL

Buffer: 1 mM Sodium Citrate, pH 6.4

Identity & Purity:

Agarose Gel Mobility; Pass

Concentration ± 5%; Pass

Product Insert
SDS

Cyanine 5 EGFP mRNA is designed for the analysis of mRNA delivery and translation efficiency. The EGFP mRNA will express an enhanced version of the green fluorescent protein, originally isolated from the jellyfish, Aequorea victoria. EGFP is a commonly used direct detection reporter in mammalian cell culture, yielding bright green fluorescence with an emission peak at 509 nm. When labeled with cyanine 5, EGFP mRNA can be directly visualized. Cyanine 5 EGFP mRNA is an ideal molecule to determine mRNA delivery and localization independent of translation.

Cyanine 5 is a synthetic fluorescent dye with maximum excitation and emission wavelengths of 650 nm and 670 nm respectively. TriLink’s CleanCap Cyanine 5 EGFP mRNA is transcribed with Cyanine 5-UTP:5-Methoxy-UTP at a ratio of 1:3. Substitution in this ratio results in mRNA that is easily visualized and can still be translated in cell culture. Translation efficiency correlates inversely with Cyanine 5-UTP substitution.

This mRNA is capped using CleanCap™, TriLink's proprietary co-transciptional capping method, which results in the naturally occuring Cap 1 structure with high capping efficiency. It is polyadenylated, modified with 5-methoxyuridine and optimized for mammalian systems. It mimics a fully processed mature mRNA.

Certificate(s) of Analysis

TD-OF03A 

L-7701 is a replacement for L-6402. 

Sold for research use only under license from Life Technologies.

Not for resale without express written permission. Not for use in humans. No license under any patent or patent pending is granted or implied by the purchase of any TriLink product. TriLink does not warrant that the use or sale of the products delivered hereunder will not infringe the claims of any United States or other patents or patents pending covering the use of the product alone or in combination with other products or in the operation of any process. All and any use of TriLink product is the purchaser’s sole responsibility.

 

 

Trinity Biotech公司G-6-PDH – Dye Reduction产品介绍

  Since its formation in 1992, Trinity Biotech has actively pursued the aim of becoming a leading player in the international diagnostics industry. A combination of strong organic growth and a progressive acquisition-led strategy has seen the company assemble an impressive portfolio of over 400 products to date.

Specialising in the development, manufacture and marketing of diagnostic test kits, Trinity Biotech’s continued success is based on the fact that as a company it consistently achieves standards of excellence in the quality of all it does.
The test kits manufactured by Trinity Biotech are used in the clinical laboratory and point-of-care segments of the diagnostic market to detect infectious diseases, sexually transmitted diseases, autoimmune and haemoglobin disorders, and detect, monitor and control diabetes. The company is also a significant provider of raw materials to the life sciences industry.
Quoted on the NASDAQ exchange, and with facilities spanning Europe and America, Trinity Biotech sells its products in more than 75 countries. It reaches this worldwide market by combining the skills of its own sales force with a network of international distributors and strategic partners.
Trinity Biotech has manufacturing facilities in:
 
Bray, Ireland – Rapids, Infectious Disease
Carlsbad, USA – Infectious Disease – Western Blot,  Point-of-care development
Acton, USA – Raw materials for supply to the research and diagnostic industries
Jamestown, USA – Infectious Disease – Enzyme Immunoassay (EIA)
Kansas City, USA –Diabetes Diagnostics based on Boronate Affinity HPLC 
 
自从1992年建立以来,Trinity Biotech 公司继续积极从事于诊断行业,目标是成为一个*者。强有机的增长和不断进步的战略模式见证了公司的荣誉。 迄今为止Trinity Biotech 公司组装过的组合已经超过了400种。
专业发展于诊断器材的销售和制造, 三一生物技术的持续成功依赖于公司始终如一的质量标准。
Trinity Biotech公司生产测试套件主要用于
临床实验室和临时诊断市场细分的探测传染病、性传播疾病、自身免疫和血红蛋白疾患、探测、监视和控制糖尿病方面。
公司也是生命科学行业理重要的原材料供应商。
 
从纳斯达克交易所获悉,三一生物技术产品已经横跨欧洲和美国热销于世界上75个国家。通过自身的技能和网络销售能力已经与世界各地的分销商形成了战略伙伴关系。
 TRINITY 公司是的临床诊断试剂及临床免疫类仪器生产供应商,*纳斯达克上市的医药企业。公司商业总部位于爱尔兰都柏林,在纽约Jamston, California,,英国warehouse, 德国,加拿大,瑞典均设有生产基地。自1992年成立以来,已在收购十多家医药生物公司。其产品范围包括自身免疫性疾病的诊断,激素类诊断试剂,药物监测,性传播疾病和传染病血清学诊断,及临床血液部门检测(Sigma),临床凝血检测(Biopool)。
 
Trinity Biotech的制造设备基地如下:
布雷,爱尔兰-急流,传染病  
卡尔斯巴德,美国-传染病,免疫印迹,现阶段的发展 
阿克顿,美国-原材料供应的研究和诊断行业 
詹姆斯敦,美国-传染病——酶免疫测定(EIA)   
堪萨斯城,美国–基于液相色谱Boronate亲和力糖尿病诊断
 
 
 
METHOD Dye Reduction, Visual Colour (qualitative)
PRINCIPLE
 
 
The rate at which the colour visually disappears in the reaction mixture is proportional to the G-6-PDH content of red cells.
 
PRODUCTBRANDCODEKIT
G-6-PDH Trizma Buffer SolutionTrinity Biotech400-4-5050 ml
G-6-PDH Dye Reduction Kit (5 assays/vial)Trinity Biotech400K-100-5X20Maximum Assays: 100
G-6-PDH Mineral Oil 1 LiterTrinity Biotech400-5-10001 L
G-6-PDH Dye Reduction Kit (10 assay/vial)Trinity Biotech400K-100XMaximum Assays: 100
G-6-PDH Mineral Oil – 100 mlTrinity Biotech400-5-100100 ml
G-6-PDH 10-Assay Vial (10 vials)Trinity Biotech400-10×1010 vials
G6PDH Substrate Kit 5 Tests/ VialTrinity Biotech400-5×1010 Vials